Delivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivo.
Eliaz
R E
RE
Department of Chemical Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Wallach
D
D
Kost
J
J
D000818:Animals; D015703:Antigens, CD / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004343:Drug Implants; D007279:Injections, Subcutaneous; D019344:Lactic Acid; D051379:Mice; D008819:Mice, Nude; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D047888:Receptors, Tumor Necrosis Factor, Type I
D015703:Antigens, CD; D003692:Delayed-Action Preparations; D004337:Drug Carriers; D004343:Drug Implants; D011108:Polymers; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid